BioCryst Pharmaceuticals Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of $1.69 billion as of October 24, 2024. Its market cap has increased by 39.54% in one year.

Market Cap

1.69B

Enterprise Value

2.25B

1-Year Change

39.54%

Ranking

#2086

Market Cap Chart

Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $1.69B, an increase of 1,585.58%. That is a compound annual growth rate of 11.52%.

Market Cap History

Date	Market Cap	% Change
Oct 23, 2024	1.67B	35.92%
Dec 29, 2023	1.23B	-42.68%
Dec 30, 2022	2.14B	-14.12%
Dec 31, 2021	2.49B	89.46%
Dec 31, 2020	1.32B	245.25%
Dec 31, 2019	381.00M	-56.94%
Dec 31, 2018	884.80M	83.11%
Dec 29, 2017	483.20M	3.49%
Dec 30, 2016	466.90M	-38.31%
Dec 31, 2015	756.80M	-13.40%
Dec 31, 2014	873.90M	94.59%
Dec 31, 2013	449.10M	522.02%
Dec 31, 2012	72.20M	-35.36%
Dec 30, 2011	111.70M	-51.92%
Dec 31, 2010	232.30M	-7.38%
Dec 31, 2009	250.80M	378.63%
Dec 31, 2008	52.40M	-77.65%
Dec 31, 2007	234.50M	-30.60%
Dec 29, 2006	337.90M	-23.72%
Dec 30, 2005	443.00M	252.71%
Dec 31, 2004	125.60M	3.37%
Dec 31, 2003	121.50M	614.71%
Dec 31, 2002	17.00M	-75.61%
Dec 31, 2001	69.70M	-40.02%
Dec 29, 2000	116.20M	-74.15%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NovoCure	1.75B
Spyre Therapeutics	1.74B
NewAmsterdam Pharma Company	1.70B
NeoGenomics	1.69B
Immunocore Holdings	1.67B
Syndax Pharmaceuticals	1.63B
ARS Pharmaceuticals	1.63B
Novavax	1.62B

Market Cap Rankings